Standout Papers
- Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer (2008)
- Ipilimumab in Combination With Paclitaxel and Carboplatin As First-Line Treatment in Stage IIIB/IV Non–Small-Cell Lung Cancer: Results From a Randomized, Double-Blind, Multicenter Phase II Study (2012)
- Phase III Study of Erlotinib in Combination With Cisplatin and Gemcitabine in Advanced Non–Small-Cell Lung Cancer: The Tarceva Lung Cancer Investigation Trial (2007)
- Ipilimumab in combination with paclitaxel and carboplatin as first-line therapy in extensive-disease-small-cell lung cancer: results from a randomized, double-blind, multicenter phase 2 trial (2012)
Immediate Impact
14 by Nobel laureates 4 from Science/Nature 116 standout
Citing Papers
Overall Survival with Osimertinib in Resected EGFR -Mutated NSCLC
2023 Standout
Toward personalized treatment approaches for non-small-cell lung cancer
2021 Standout
Works of Piotr Serwatowski being referenced
Adjuvant Erlotinib Versus Placebo in Patients With Stage IB-IIIA Non–Small-Cell Lung Cancer (RADIANT): A Randomized, Double-Blind, Phase III Trial
2015
Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer
2008 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Piotr Serwatowski | 3964 | 3489 | 1035 | 28 | 5.2k | |
| Francesco Orlandi | 4788 | 3109 | 764 | 39 | 5.4k | |
| Aleksandra Szczęsna | 4355 | 4084 | 1163 | 71 | 5.6k | |
| Willemijn S.M.E. Theelen | 2945 | 3222 | 971 | 33 | 4.2k | |
| Gene Grant Finley | 3795 | 2613 | 1028 | 70 | 4.9k | |
| Ariel López-Chávez | 2711 | 1853 | 805 | 41 | 3.6k | |
| Ellie Im | 4751 | 3019 | 494 | 28 | 5.4k | |
| Diane Prager | 3429 | 3407 | 1552 | 54 | 5.3k | |
| John Grous | 4006 | 2566 | 949 | 23 | 5.0k | |
| Robert M. Jotte | 5491 | 3913 | 1386 | 109 | 6.7k | |
| Catherine Dubos Arvis | 4670 | 3115 | 429 | 16 | 5.2k |
All Works
Loading papers...